Castle Creek Arbitrage, LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAC8. A total of 17 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Castle Creek Arbitrage, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2014$17,779,000
+3.7%
13,446,0000.0%0.85%
-14.8%
Q3 2014$17,142,000
-20.4%
13,446,0000.0%1.00%
-26.6%
Q2 2014$21,531,000
+23.7%
13,446,000
+5.5%
1.36%
+51.1%
Q1 2014$17,400,000
-26.3%
12,751,000
-26.5%
0.90%
-12.9%
Q4 2013$23,595,000
+6.8%
17,350,0000.0%1.04%
+4.7%
Q3 2013$22,103,000
+2.8%
17,350,0000.0%0.99%
+1.4%
Q2 2013$21,507,00017,350,0000.98%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2014
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 20,750,000$25,781,0003.35%
Sage Capital Management, LLC 2,500,000$3,092,0003.23%
WHITEBOX ADVISORS LLC 24,874,000$30,844,0001.62%
Castle Creek Arbitrage, LLC 17,350,000$21,507,0000.98%
GUARDIAN LIFE INSURANCE CO OF AMERICA 4,598,000$5,673,0000.52%
WOLVERINE ASSET MANAGEMENT LLC 15,690,000$19,386,0000.50%
AMUNDI ASSET MANAGEMENT US, INC. 25,195,000$31,084,0000.13%
Cutler Capital Management, LLC 237,000$292,0000.13%
PALISADE CAPITAL MANAGEMENT, LP 3,500,000$4,371,0000.13%
LAZARD ASSET MANAGEMENT LLC 14,457,000$17,836,0000.04%
View complete list of PDL BIOPHARMA INC shareholders